Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 46.63B | 50.93B | 67.44B | 59.69B | 45.28B |
Gross Profit | 7.61B | 8.24B | 10.81B | 9.14B | 6.56B |
EBITDA | 2.93B | 3.34B | 5.01B | 3.64B | 1.63B |
Net Income | 1.79B | 2.09B | 3.31B | 2.34B | 889.41M |
Balance Sheet | |||||
Total Assets | 29.10B | 28.30B | 33.37B | 32.74B | 26.44B |
Cash, Cash Equivalents and Short-Term Investments | 8.13B | 6.17B | 6.08B | 6.15B | 5.91B |
Total Debt | 722.43M | 1.15B | 2.47B | 2.10B | 645.65M |
Total Liabilities | 10.41B | 9.83B | 14.76B | 15.11B | 10.05B |
Stockholders Equity | 18.69B | 18.47B | 18.61B | 17.63B | 16.40B |
Cash Flow | |||||
Free Cash Flow | 3.90B | 3.71B | 2.01B | -472.81M | 2.45B |
Operating Cash Flow | 3.94B | 3.79B | 2.90B | 426.21M | 2.51B |
Investing Cash Flow | -30.33M | 28.58M | -897.98M | -696.80M | 671.08M |
Financing Cash Flow | -1.96B | -3.74B | -2.09B | 497.35M | -1.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥17.80B | 7.47 | 1.08% | 3.43% | 16.71% | ||
80 Outperform | ¥21.42B | 10.63 | 3.11% | 10.29% | 50.74% | ||
78 Outperform | ¥38.63B | 10.05 | 2.09% | -0.70% | -17.98% | ||
76 Outperform | ¥23.51B | 13.24 | 7.60% | -8.44% | -14.55% | ||
75 Outperform | ¥46.38B | 10.40 | 1.18% | 8.33% | 10.87% | ||
68 Neutral | ¥45.45B | 48.46 | 5.07% | -34.71% | -101.43% | ||
65 Neutral | $10.86B | 15.57 | 5.28% | 1.92% | 3.13% | -27.76% |